XML 45 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Derivative Liability - Additional Information (Detail) - Product Approval Payment Derivative - USD ($)
$ in Millions
6 Months Ended 12 Months Ended
Jun. 30, 2020
Dec. 31, 2019
Valeant Pharmaceuticals International, Inc.    
Settlement And Termination [Line Items]    
Nonrecurring milestone payment $ 4.0  
Medicis Pharmaceutical Corporation    
Settlement And Termination [Line Items]    
Fair value of derivative $ 3.1 $ 3.0
Measurement Input, Expected Term | Medicis Pharmaceutical Corporation    
Settlement And Termination [Line Items]    
Fair value, measurement input, duration 4 months 24 days 10 months 24 days
Measurement Input, Entity Credit Risk | Medicis Pharmaceutical Corporation    
Settlement And Termination [Line Items]    
Fair value, measurement input (percent) 7.50% 7.50%
Measurement Input, Risk Free Interest Rate | Medicis Pharmaceutical Corporation    
Settlement And Termination [Line Items]    
Fair value, measurement input (percent) 0.20% 1.60%